Literature DB >> 5435226

Human porphyria cutanea tarda. Isolation and properties of the urinary porphyrins.

S Nacht, L C San Martín de Viale, M Grinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5435226     DOI： 10.1016/0009-8981(70)90297-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.

Authors:  J P Kushner; D P Steinmuller; G R Lee
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

Review 3.  Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

Authors:  G Romeo
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

4.  An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.

Authors:  J P Kushner; A J Barbuto; G R Lee
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

5.  A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.

Authors:  John D Phillips; Hector A Bergonia; Christopher A Reilly; Michael R Franklin; James P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

6.  Porphyrins and porphyrinogen carboxy-lase in hexachlorobenzene-induced porphyria.

Authors:  L C San Martín De Viale; M D Ríos De Molina; R W De Calmanovici; J M Tomio
Journal:  Biochem J       Date:  1977-12-15       Impact factor: 3.857

7.  The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model.

Authors:  J P Kushner; G R Lee; S Nacht
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.